| |
| |
|
| Insider
Information: |
Klein Joseph III |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
86,717 |
|
|
Indirect Shares
|
111 |
|
|
| Direct
Value |
$3,780,675 |
|
|
|
Indirect Value
|
$3,922 |
|
|
| Total
Shares |
86,828 |
|
|
| Total
Value |
$3,784,597 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
3
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
-3.0
|
| Percentage
Gain/Loss : |
 127.5%
|
 -75.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
NPS Pharmaceuticals Inc |
NPSP |
as of May 22, 2007 |
2007-05-23 |
0 |
2003-09-11 |
0 |
Premium* |
|
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2010-03-08 |
35,000 |
2007-03-07 |
0 |
Premium* |
|
|
Clinical Data Inc |
CLDA |
Former Director |
2006-10-11 |
1,000 |
|
0 |
Premium* |
|
|
Ionis Pharmaceuticals Inc |
IONS |
Director |
2024-05-03 |
16,346 |
2024-05-03 |
100 |
Premium* |
|
|
Savient Pharmaceuticals Inc |
SVNTQ |
Director |
2010-06-08 |
17,388 |
2006-06-01 |
0 |
Premium* |
|
|
PDL Biopharma Inc |
PDLI |
Director |
2009-11-04 |
16,983 |
2009-11-04 |
11 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
178 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2006-06-15 |
4 |
AB |
$5.71 |
$17,130 |
D/D |
3,000 |
26,000 |
2.39 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2006-07-03 |
4 |
AB |
$5.34 |
$16,020 |
D/D |
3,000 |
29,000 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2006-07-18 |
4 |
AB |
$5.19 |
$15,570 |
D/D |
3,000 |
32,306 |
2.39 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2006-08-01 |
4 |
AB |
$5.88 |
$17,640 |
D/D |
3,000 |
35,306 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2006-08-15 |
4 |
AB |
$5.79 |
$17,370 |
D/D |
3,000 |
38,306 |
2.39 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2006-09-01 |
4 |
AB |
$6.50 |
$19,494 |
D/D |
3,000 |
41,306 |
2.39 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2006-09-15 |
4 |
AB |
$6.30 |
$18,900 |
D/D |
3,000 |
44,306 |
2.39 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2017-11-13 |
4 |
AS |
$55.39 |
$166,170 |
D/D |
(3,000) |
7,127 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2017-11-30 |
4 |
AS |
$53.55 |
$160,650 |
D/D |
(3,000) |
9,939 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2017-11-30 |
4 |
OE |
$28.47 |
$85,410 |
D/D |
3,000 |
12,939 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2017-12-15 |
4 |
OE |
$28.47 |
$85,410 |
D/D |
3,000 |
12,939 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2017-12-15 |
4 |
AS |
$51.69 |
$155,070 |
D/D |
(3,000) |
9,939 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2017-12-29 |
4 |
AS |
$50.56 |
$151,680 |
D/D |
(3,000) |
9,939 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2017-12-29 |
4 |
OE |
$28.47 |
$85,410 |
D/D |
3,000 |
12,939 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2018-01-16 |
4 |
AS |
$52.13 |
$157,566 |
D/D |
(3,000) |
9,939 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2018-01-16 |
4 |
OE |
$35.53 |
$106,590 |
D/D |
3,000 |
11,339 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2018-01-30 |
4/A |
OE |
$35.53 |
$106,590 |
D/D |
3,000 |
12,939 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2018-01-30 |
4/A |
AS |
$52.86 |
$158,580 |
D/D |
(3,000) |
9,939 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2018-02-15 |
4 |
AS |
$48.76 |
$146,984 |
D/D |
(3,000) |
9,939 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2018-02-15 |
4 |
OE |
$35.53 |
$106,590 |
D/D |
3,000 |
11,539 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2018-02-28 |
4 |
AS |
$51.02 |
$155,727 |
D/D |
(3,000) |
9,939 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2018-02-28 |
4 |
OE |
$35.53 |
$106,590 |
D/D |
3,000 |
12,039 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
Director |
– • – |
2004-01-06 |
4 |
A |
$31.60 |
$97,960 |
D/D |
3,100 |
3,100 |
|
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2007-05-15 |
4 |
A |
$12.77 |
$41,847 |
D/D |
3,277 |
48,804 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2010-06-08 |
4/A |
A |
$0.00 |
$0 |
D/D |
3,514 |
17,388 |
0 |
- |
|
178 Records found
|
|
Page 5 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
